# A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants

> **NCT05877053** · PHASE1 · COMPLETED · sponsor: **Cytokinetics** · enrollment: 102 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** CK-4021586
- **DRUG:** Placebo for CK-4021586

## Key facts

- **NCT ID:** NCT05877053
- **Lead sponsor:** Cytokinetics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-09
- **Primary completion:** 2024-11-20
- **Final completion:** 2024-11-20
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2025-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05877053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05877053, "A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05877053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*